Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07480018

Berberine Supplementation, Sprint Interval Training, and Immune Function Study

Effects of 2-Weeks of Berberine and Sprint Interval Training on Wellbeing, Anaerobic Power, and Monocyte Number and Function

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Northern Colorado · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this clinical trial is to investigate the effects of a 2-week intervention involving berberine supplementation or sprint training in isolation as well as berberine combined with sprint training on well-being, anaerobic power, and monocyte number and function in individuals experiencing mild mental health challenges. The main questions it aims to answer are: * Does short-term berberine use or sprint training improve measures of mental health, psychological wellbeing, fatigue, and sleep quality? * Does short-term berberine use or sprint training improve measures of anaerobic power generation? * Does short-term berberine use or sprint training improve circulating biomarkers of inflammation? * Does short-term berberine use or sprint training improve monocyte number, function, and cytokine production?

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBerberineConsumption of a commercially-available Berberine supplement at a dosage of 500mg, Three times per day with meals, for a total dosage of 1500mg/day.
OTHERPlaceboConsumption of placebo capsules composed of rice flour at a dosing of 3 capsules per day with meals.
OTHERSprint Interval TrainingMultiple sets of maximal effort 30 second sprints, inter spaced with 4 minutes of rest/active recovery, on the cycle ergometer over the course of 6 sessions during the 2-Week intervention. Resistance for each set is calculated at 7.5% of the body mass of the participant. Sets for each session are as follows: (1) 4 Sets, (2) 5 Sets, (3) 6 Sets, (4) 6 Sets, (5) 7 Sets, (6) 4 Sets.

Timeline

Start date
2026-01-01
Primary completion
2026-05-01
Completion
2026-06-01
First posted
2026-03-18
Last updated
2026-03-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07480018. Inclusion in this directory is not an endorsement.